Top Markets
#1 Islamic Coin Islamic Coin +151.57%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +17.99%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.03%
#4 clBTC clBTC +12.26%
#5 OpenEden OpenEden +10.90%
#6 Wrapped Ether (Mantle Bridge) Wrapped Ether (Mantle Bridge) +8.95%
#7 MarsCoin MarsCoin +8.78%
#8 Mantle Staked Ether Mantle Staked Ether +8.43%
#9 Mantle Restaked ETH Mantle Restaked ETH +8.23%
#10 Akedo Akedo +8.03%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Solvonis Therapeutics plc Solvonis Therapeutics plc

Solvonis Therapeutics plc

SVNS
Rang in Aktien #40469
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January... Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN: These are reactive solid super-concentrates engineered to enhance polyolefin rheology, boost e-modulus, act as chain extenders for PET/PBT, and serve as AOX masterbatches. GRAFTAPOR: Comprising porous polymer-carriers, this line is specifically developed for applications involving liquid chemicals. GRAFTAMID: This series includes high-temperature elastomers, based on nanostructured polyolefin-polyamide alloys. They function as advanced hardening modifiers within polyamide compounds or as standalone components in hot melt adhesive formulations. GRAFTAKIT: Offering reactive liquid or solid super-concentrates embedded in polymeric porous media, GRAFTAKIT is used to optimize reaction extrusion and the modification of compounds. GRAFTALLOY: A range of polymer-polymer nano-alloys crafted to significantly improve abrasion and temperature resistance, boost impact strength, and reduce friction. GRAFTASYNT: This line encompasses synthetic products, notably including halogen-free flame retardants. GRAFTAMER: An innovative smart polymer characterized by thermo-reversible crosslinking, self-hardening, self-healing properties, and shape memory capabilities. The company was founded in 2017 and maintains its headquarters in London, United Kingdom.
Aktienkurs
$0.00204105
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$138.92K
Veränderung (1 Tag)
5.63%
Veränderung (1 Jahr)
-51.33%
Land
GB
Handel Solvonis Therapeutics plc (SVNS)

Kategorie

Industrials
Aktien-Split-Historie für Solvonis Therapeutics plc (SVNS)
Die Aktie Solvonis Therapeutics plc (Symbol: SVNS) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 14, 2026 statt.
Eine SVNS-Aktie, die vor dem Aug 14, 2026 gekauft wurde, entspricht heute 0 SVNS-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Lam Research Corp. R Lam Research Corp. R
Lam Research Corp. R
LAR0.DE
 0 -
US
Siemens AG Siemens AG
Siemens AG
SIE.DE
 2 x15
DE
Schneider Electric S.E. Schneider Electric S.E.
Schneider Electric S.E.
SU.PA
 0 -
FR
Siemens Energy AG Siemens Energy AG
Siemens Energy AG
ENR.DE
 0 -
DE
Parker-Hannifin Corporation Parker-Hannifin Corporation
Parker-Hannifin Corporation
PH.US
 6 x11
US